Skip to content

Use of Er-YAG laser for treating acne scars

Efficacy and safety of fractional Erbium-YAG laser in patients with atrophic acne scars: a prospective interventional study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085033
Enrollment
30
Registered
2025-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L708- Other acne

Interventions

Intervention1: Erbium YAG laser 2940nm: Test patch was done at 1400mJ long mode and patients were monitored for any adverse events. If test patch was eventful 4 sessions of 2 passes of Er-YAG laser we

Sponsors

Department of Dermatology Institute of Medical Sciences Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients presenting with Goodman and Baron Grade II III and IV acne scars. Males and females in the age group of 18 to 40 years. Motivated patients willing to come for follow-up.

Exclusion criteria

Exclusion criteria: Presence of active acne lesions. Patients having keloids or a keloidal tendency. History of any bleeding disorder and slash or patients taking anticoagulants. Patients taking oral steroids. Active skin infections like warts, herpes, or any bacterial infection. Pregnancy and lactation. Patients taking high dose isotretinoin. Patients having undergone any surgery or procedure for acne scars in the preceding three months.

Design outcomes

Primary

MeasureTime frame
Assessment of improvement in acne scars using Goodman and Baron quantitative grading system.Timepoint: Assessment of improvement in acne scars using Goodman and Baron quantitative grading system at every 4 weeks for 4 months.

Secondary

MeasureTime frame
NoneTimepoint: None

Countries

India

Contacts

Public ContactAtul Mohan

Institute of Medical Sciences, Banaras Hindu University

dratulmohan1994@gmail.com8650315384

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026